U.S. Markets open in 1 hr 11 mins

Atrion Corporation (ATRI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
656.00-0.10 (-0.02%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close656.10
Open651.50
Bid0.00 x 800
Ask0.00 x 800
Day's Range651.50 - 656.00
52 Week Range579.00 - 846.15
Volume2,052
Avg. Volume5,620
Market Cap1.2B
Beta (5Y Monthly)0.15
PE Ratio (TTM)34.62
EPS (TTM)18.95
Earnings DateOct 30, 2020 - Nov 03, 2020
Forward Dividend & Yield6.20 (0.94%)
Ex-Dividend DateJun 12, 2020
1y Target EstN/A
  • GlobeNewswire

    Atrion Reports Second Quarter Results

    ALLEN, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that for the second quarter ended June 30, 2020, revenues totaled $38.0 million compared with $40.1 million for the same period in 2019. Net income for the second quarter of 2020 totaled $8.6 million as compared to $9.7 million for the same period in 2019, with diluted earnings per share for the second quarter of 2020 at $4.68 compared to $5.18 for the second quarter of 2019. Commenting on the Company’s quarterly results for the second quarter of 2020 compared to the same period last year, David A. Battat, President & CEO, stated, “The impact of the pandemic was felt in the second quarter with revenues and operating income lower by 5% and 8%, respectively, essentially the reverse image of the first quarter when revenues were up 5% and operating income was up 6%.” Mr. Battat explained, “The current year second quarter saw hospitals suspend elective surgeries to preserve ICU beds and other resources to deal with the anticipated deluge of Covid-19 patients. As a result, sales of our products used in elective procedures were lower by $3.7 million.” Mr. Battat added, “The net impact on overall sales was limited to $2.1 million thanks to our diversified product portfolio and the tireless efforts of my co-workers who kept our operations running throughout this period.” Mr. Battat continued “With an effective tax rate 15% higher in this year’s quarter than the prior year’s second quarter, diluted EPS and net income were lower by 10% and 11%, respectively. During the quarter we purchased 12,158 shares of our common stock at an average cost of $641 per share. As of June 30, 2020, we continue to be debt free while holding $87.5 million in cash and short and long term investments.”Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com. ATRION CORPORATION UNAUDITED CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) Three Months Ended June 30, Six Months Ended June 30,   2020   2019   2020   2019  Revenues$  37,968  $  40,103  $  81,563  $  81,717  Cost of goods sold   20,499     21,511     44,226     44,422    Gross profit   17,469     18,592     37,337     37,295  Operating expenses   7,423     7,626     15,577     15,291    Operating income   10,046     10,966     21,760     22,004           Interest and dividend income   367     581       858       1,163  Other investment income (loss)     354       161       (673)      372  Income before income taxes   10,767     11,708     21,945     23,539  Income tax provision   (2,162)    (2,044)    (4,443)    (4,437)   Net income$    8,605  $    9,664  $17,502  $19,102           Income per basic share$    4.69  $    5.21  $    9.49  $    10.30           Weighted average basic shares   outstanding   1,835     1,854     1,844     1,854                    Income per diluted share$    4.68  $    5.18  $    9.47  $    10.25           Weighted average diluted shares   outstanding   1,839     1,864     1,849     1,863                      ATRION CORPORATION CONSOLIDATED BALANCE SHEETS (In thousands) June 30, Dec. 31, ASSETS 2020  2019  (Unaudited)   Current assets:      Cash and cash equivalents$  24,099 $  45,048   Short-term investments   6,574    23,766     Total cash and short-term investments   30,673    68,814   Accounts receivable   22,441    18,886   Inventories   45,805    42,093   Prepaid expenses and other   3,226    2,545     Total current assets   102,145    132,338   Long-term investments   56,871    31,772   Property, plant and equipment, net   87,867    84,606 Other assets   13,467    13,315       $  260,350 $  262,031           LIABILITIES AND STOCKHOLDERS’ EQUITY         Current liabilities   15,443    11,274 Line of credit   --    -- Other non-current liabilities   11,380    12,887 Stockholders’ equity   233,527    237,870       $  260,350 $  262,031 Contact:     Jeffery Strickland Vice President and Chief Financial Officer (972) 390-9800

  • Declining Stock and Solid Fundamentals: Is The Market Wrong About Atrion Corporation (NASDAQ:ATRI)?
    Simply Wall St.

    Declining Stock and Solid Fundamentals: Is The Market Wrong About Atrion Corporation (NASDAQ:ATRI)?

    With its stock down 6.1% over the past three months, it is easy to disregard Atrion (NASDAQ:ATRI). However, a closer...